Although the United States added the recent decline in unemployment, but the national unemployment rate remains high. Experts estimate that the recovery of the U.S. job market at least one to two years. Nevertheless, some industries are still optimistic about employment prospects. In today's "future hot jobs" series report, we introduce you: pharmaceutical industry.
The United States recently a wave of unemployment affects many industries. Finance, manufacturing, construction and service industries bear the brunt of some of the areas. But some industries are relatively small impact of the recession. The pharmaceutical industry is a typical "anti-recession" (recession proof) industry.
U.S. Department of Labor Bureau of Labor Statistics released the 2010-2011 version of Guidance for Industry estimates, the pharmaceutical industry in the United States provided 280,009 thousand eight hundred jobs. The next 8 years, is expected to force the industry to expand 6 per cent of employment.
The pharmaceutical industry consulting firm, president of the League of ACET Patrick Dixon (Patrick Dixon) said that, in addition to medical and health needs of people more rigid, less affected by the economic cycle, the pharmaceutical industry is also optimistic about employment prospects and the United States and other industrialized countries, increased population aging.
He said: "Most of the pharmaceutical company's sales are from 65-75 percent of people over the age of 65. Most of the developed countries, about 75 percent of health care budget is used for this population. Simply put, Most pharmaceutical companies exist primarily to provide products to the elderly. Of course, children and other age groups is their sales targets, but older people is the most important. the next 5 years, 10 years, 15 years, this market is the largest share of demand and sales where. "
Department of Labor Bureau of Labor Statistics reports that, in addition to demographic factors, the pharmaceutical companies in cancer, AIDS, Alzheimer's disease (Alzheimer's) continuing research and development of drugs and other diseases will also increase employment in the industry to provide protection.
ACET Paddy Jackson, president of the League, said the employment prospects of the pharmaceutical industry in the developing world is also good.
He said: "In fact, the global health care are expanding the size of the budget. Not only in developed countries, developing countries. We need to improve the pharmaceutical industry to provide solutions to our health. Therefore, government, health insurance companies, individuals face greater pressure to increase investment in the pharmaceutical industry. "
According to the U.S. Bureau of Labor Statistics, the U.S. pharmaceutical industry, 31 percent of jobs in science and technology research and development, 27 percent in low-skilled and high-tech manufacturing sectors. The remaining jobs are management, office, and other administrative staff.
There are mainly three types of U.S. pharmaceutical companies. The first is already approved drugs on the market of large pharmaceutical companies. These enterprises are usually in the country and the world has a large R & D facilities. The second type is smaller, there is no approved pharmaceutical products to market sales of pharmaceutical companies. These companies usually means contracting for other pharmaceutical companies to carry out research and development. The third company specializing in the production of generic drugs patents have expired. Major investments in such enterprises are usually in production, less research and development.
ACET, president of the League of Jackson, said Paddy, and many other economic recession in the industry by the government bailout barrier, the prospects for the pharmaceutical industry mainly depends on the private sector.
"The innovative pharmaceutical industry will not rely on government-funded institutions, but mainly from the private sector. Small startup biotech companies will introduce their innovations to large enterprises, these enterprises use their own resources to carry out comprehensive clinical trials the drug into the market finally. "
R & D in the areas of the pharmaceutical industry, practitioners minimum academic qualification is a four-year bachelor of science degree. However, the personnel directly involved in drug development usually have master's or higher degree. For pharmaceutical scientists, PhD is usually the minimum requirement, and directly involved in clinical trials, drug development need a medical position.
In the technical aspects, the pharmaceutical industry on the requirements of job seekers in the technical colleges are usually required to complete community college or chemical, biological, mathematical, or engineering courses. In the production of the manufacturing sector, the general experience is not necessary, training is usually done at work.
ACET International Alliance president Paddy Jackson said that although the pharmaceutical industry, promising, but not without challenges.
"Regulators always glued to these enterprises. The image of pharmaceutical companies in general is not very good, they are not media friendly. Shareholders often require short-term benefits, but in this industry, from research to market a new drug usually takes 15 years time, then take 10 years to recover the costs. "
U.S. Department of Labor Bureau of Labor Statistics reports that the increasingly high development costs, competition from emerging markets, intellectual property infringement, and the degree of mechanization is also the pharmaceutical industry to improve employment prospects facing the potential threat.
没有评论:
发表评论